Drugmakers that were selected in early February to begin price negotiations for 10 of the most expensive drugs in the U.S. as part of the Biden administration’s Inflation Reduction Act have sent the federal government counteroffers, President Joe Biden confirmed in a March 4 update.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
